Connective tissue activation. IV. Regulatory effects of antirheumatic drugs.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D003238:Connective Tissue / Q000187:drug effects / Q000378:metabolism*; D046508:Culture Techniques; D005122:Exudates and Transudates; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006046:Gold / Q000494:pharmacology; D006801:Humans; D006820:Hyaluronic Acid / Q000096:biosynthesis*; D006854:Hydrocortisone / Q000494:pharmacology; D006886:Hydroxychloroquine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D013870:Thiomalates / Q000494:pharmacology; D014945:Wound Healing / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D007773:Lactates; D010455:Peptides; D012459:Salicylates; D013870:Thiomalates; D006886:Hydroxychloroquine; D006046:Gold; D002738:Chloroquine; D006820:Hyaluronic Acid; D010653:Phenylbutazone; D005947:Glucose; D003078:Colchicine; D006854:Hydrocortisone; D007213:Indomethacin